Reaction
Which drugs are most reported with Dermatitis bullous?
As of the last recalculation, Dermatitis Bullous appears in 7,099 FAERS reports alongside 304 co-occurring drug terms. The strongest observed disproportionality signal is LINAGLIPTIN (PRR 37.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.